Cubist Systematic Strategies, LLC Illumina, Inc. Put Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $84,224 - $108,720	800 Added 10.53%	8,400 $1.1 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $3.82 Million - $5.05 Million	-37,800 Reduced 83.26%	7,600 $793,000
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $1.94 Million - $2.24 Million	-15,200 Reduced 25.08%	45,400 $6.23 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $4.36 Million - $6.7 Million	47,000 Added 345.59%	60,600 $8.44 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $721,896 - $1.08 Million	5,600 Added 70.0%	13,600 $1.87 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $880,464 - $1.12 Million	4,800 Added 150.0%	8,000 $1.5 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $1.72 Million - $2.07 Million	-8,900 Reduced 73.55%	3,200 $744,000
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $7.53 Million - $9.76 Million	-40,200 Reduced 76.86%	12,100 $2.45 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $496,244 - $636,832	2,800 Added 5.66%	52,300 $9.98 Million
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $8.99 Million - $18.2 Million	49,500 New	49,500 $9.13 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.